SPU [Future FinTech] 10-Q:

[] [RULE 13a-14(a) CERTIFICATION FOR FORM 10-Q (CEO) CERTIFICATION I, Shanchun Huang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Future FinTech Group Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a mat]

By | 2020-10-01T09:48:31+00:00 July 6th, 2020|Categories: Chinese Stocks, SPU, Webplus ver|Tags: , , , , , |0 Comments

NTES [NetEase] 6-K: Unless otherwise defined in this announcement, capitalized terms

[Unless otherwise defined in this announcement, capitalized terms used herein shall have the same meanings as those defined in the Hong Kong prospectus dated June 2, 2020 issued by NetEase, Inc. NetEase, Inc. (Incorporated in the Cayman Islands with limited liability) (Stock Code: 9999) STABILIZING A]

By | 2020-10-01T14:04:01+00:00 July 6th, 2020|Categories: Chinese Stocks, NTES, Webplus ver|Tags: , , , , , |0 Comments

HIMX [Himax Technologies] 6-K: (Original Filing)

[Himax Technologies, Inc. Pre-announces Preliminary Unaudited Second Quarter 2020 Financial Results Revenues, Gross Margin and EPS all Exceed Guidance th th TAINAN, Taiwan, July 06, 2020 (GLOBE NEWSWIRE) -- Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax” or “Company”), a leading supplier and fabless]

By | 2020-10-01T10:03:18+00:00 July 6th, 2020|Categories: Chinese Stocks, HIMX, SEC Original|Tags: , , , , , |0 Comments

HIMX [Himax Technologies] 6-K: Himax Technologies, Inc. Pre-announces Preliminary Unaudited Second Quarter

[Himax Technologies, Inc. Pre-announces Preliminary Unaudited Second Quarter 2020 Financial Results Revenues, Gross Margin and EPS all Exceed Guidance th th TAINAN, Taiwan, July 06, 2020 (GLOBE NEWSWIRE) -- Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax” or “Company”), a leading supplier and fabless]

By | 2020-10-01T10:03:22+00:00 July 6th, 2020|Categories: Chinese Stocks, HIMX, Webplus ver|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac COVID-19 Vaccine Collaboration with Butantan Receives Approval from Brazilian Regulator for Phase III Trial Beijing-July 6, 2020 — Sinovac Biotech Ltd. ( “Sinovac” or the “ Company”)(Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced an update to its pre]

By | 2020-10-01T15:37:32+00:00 July 6th, 2020|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: Sinovac COVID-19 Vaccine Collaboration with Butantan Receives Approval

[Sinovac COVID-19 Vaccine Collaboration with Butantan Receives Approval from Brazilian Regulator for Phase III Trial Beijing-July 6, 2020 — Sinovac Biotech Ltd. ( “Sinovac” or the “ Company”)(Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced an update to its pre]

By | 2020-10-01T15:37:36+00:00 July 6th, 2020|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar